SG Americas Securities
LYEL icon

SG Americas Securities’s Lyell Immunopharma LYEL Stock Holding History

SG Americas Securities’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,594
Closed -$39K – 3318
2025
Q1 		$39K Sell
3,594
-2,243
-38% -$27.5K ﹤0.01% 3294
2024
Q4 		$75K Buy
5,837
+2,959
+103% +$58.7K ﹤0.01% 2816
2024
Q3 		$79K Buy
2,878
+1,262
+78% +$37.1K ﹤0.01% 3139
2024
Q2 		$47K Sell
1,616
-1,797
-53% -$85.5K ﹤0.01% 2683
2024
Q1 		$152K Sell
3,413
-1,548
-31% -$66.3K ﹤0.01% 2192
2023
Q4 		$192K Buy
4,961
+2,234
+82% +$80.4K ﹤0.01% 2203
2023
Q3 		$80K Buy
+2,727
New +$129K ﹤0.01% 2851
2023
Q2 		– Sell
-3,398
Closed -$160K – 2792
2023
Q1 		$160K Buy
3,398
+324
+11% +$17.3K ﹤0.01% 2591
2022
Q4 		$213K Buy
3,074
+730
+31% +$72.5K ﹤0.01% 2149
2022
Q3 		$344K Sell
2,344
-2,032
-46% -$275K ﹤0.01% 1875
2022
Q2 		$571K Buy
4,376
+421
+11% +$43K 0.01% 1853
2022
Q1 		$399K Buy
+3,955
New +$479K ﹤0.01% 2023
2021
Q4 		– Sell
-531
Closed -$157K – 3631
2021
Q3 		$157K Buy
+531
New +$159K ﹤0.01% 3396

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SG Americas Securities's LYEL Position: Q2 2025 in Review

SG Americas Securities sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 3,594 shares — an estimated $39K sold.

SG Americas Securities first reported a position in LYEL in Q3 2021 and held it in 13 quarters. The position peaked at $571K in Q2 2022. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • SG Americas Securities reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 3,594 Lyell Immunopharma shares in Q2 2025, an estimated $39K.
  • SG Americas Securities first reported a position in Lyell Immunopharma in Q3 2021 and held it in 13 quarters.
  • SG Americas Securities's Lyell Immunopharma position peaked at $571K in Q2 2022.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.